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Metabolic acidosis up-regulates PTH/PTHrP receptors in the physicochemical dissolution of bone as excess pro-
UMR 106-01 osteoblast-like cells. tons are buffered by bone carbonate. Studies by Bushin-
Background. Metabolic acidosis results in skeletal deminer- sky et al, using neonatal mouse calvariae, have shownalization by multiple mechanisms. One of these involves the
that when the culture medium is acutely acidified byinorganic phase of bone by which hydrogen ion is buffered by
reducing bicarbonate concentration, there is a net influxbone carbonate. In addition, the cellular components of bone
participate by the induction and repression of several skeletal of protons with concomitant calcium efflux from the
genes. Previous studies have suggested that the action of para- bone secondary to dissolution of bone calcium carbonate
thyroid hormone (PTH), a major regulator of bone turnover, [1–4]. In addition, the cellular components of bone maymight be altered by acidosis. The present studies were designed
participate in the process of skeletal demineralizationto test directly, in vitro, whether acidosis altered the effects of
induced by acidosis. Goldhaber and Rabadjija demon-PTH in UMR 106-01 osteoblast-like cells.
Methods. Studies were conducted in confluent cultures of strated that the calcium release from neonatal mouse
UMR 106-01 cells in modified Eagle’s medium (MEM) with calvariae cultured for one week in acidic medium oc-
5% fetal bovine serum (FBS) at pH values varying from 7.4
curred only in live but not dead bone [5]. Histologicto 7.1 by addition of HCl. After time periods of 4 to 48 hours,
examination of the resorbed calvariae demonstrated thecells were tested for cyclic AMP generation in response to
PTH. PTH binding and PTH/PTHrP receptor mRNA levels presence of numerous osteoclasts in different stages of
were determined by radioligand binding assay and Northern bone destruction; in addition, thyrocalcitonin, an inhibi-
analysis respectively. tor of osteoclastic function abolished the proton-medi-
Results. After 48 hours, decreases in pH from 7.4 to 7.1 re-
ated calcium release. This finding established the role ofsulted in a progressive increase in PTH-stimulated cyclic-AMP
bone cells in skeletal demineralization during chronicgeneration from 1978  294 to 4968  929 pmol/culture/5 min
(P  0.05). Basal cyclic AMP concentrations were unchanged. metabolic acidosis. Similar findings were reported by
PTH binding increased 1.5- to twofold. Competitive inhibition Bushinsky [6]. Additional studies on the direct effect of
binding revealed an increase in receptor number supported by metabolic acidosis on bone cells suggested that metabolicup-regulation of PTH/PTHrP receptor mRNA up to twofold
acidosis inhibits osteoblast but stimulates osteoclastfrom control levels.
function [7, 8]. Krieger, Sessler and Bushisky reportedConclusions. These findings demonstrate that metabolic
acidosis stimulates the response to PTH in UMR 106-01 osteo- inhibition of osteoblastic collagen synthesis in calvariae
blast-like cells by a mechanism that involves an increase in incubated in acidified medium while there was enhance-
the levels of PTH/PTHrP receptor mRNA. Thus, the skeletal ment of osteoclastic -gucuronidase activity [7].response to acidosis that includes an increase in bone resorp-
The role of PTH on skeletal demineralization in meta-tion may result, at least in part, from an increase in PTH/
bolic acidosis remains elusive. Martin et al studied thePTHrP receptors leading to an enhanced effect of PTH on
bone. effect of acute acidosis on the uptake and action of PTH
in isolated perfused canine tibiae. Lowering the pH of
the perfusate by addition of HCl resulted in an increase
Metabolic acidosis results in skeletal demineralization in the arteriovenous difference for intact PTH (iPTH)
by multiple mechanisms. One of these processes involves across the perfused bone. Basal and PTH stimulated
cyclic adenosine 3,5-monophosphate (cAMP) genera-
tion also increased significantly under acidic conditionsKey words: parathyroid hormone, cyclic AMP, osteoblasts, bone de-
mineralization. [9]. Using neonatal mouse calvariae, Bushinsky and Nils-
son studied the effect of PTH and metabolic acidosis onReceived for publication February 11, 2002
osteoblast and osteoclast function. The combination ofand in revised form April 24, 2002
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uronidase activity and inhibition of osteoblastic collagen 75g of sodium metabisulfite and 0.5 mL of 20% acetoni-
trile (ACN) in 0.1% trifluoroacetic acid (TFA) was added.synthesis than either treatment alone [10]. These findings
suggest that metabolic acidosis may enhance the actions This was applied to a SepPak C18 cartridge (Waters Chro-
matography Division, Milford, CA, USA) which hadof PTH on bone cells. The present experiments were
designed to examine the direct effect of metabolic acido- been equilibrated sequentially with 3 mL of 100% ACN,
5 mL of 80% ACN, 0.1% TFA and finally with 5 mLsis on PTH/PTHrP receptors in UMR106-01 osteoblast
like cells. of 20% ACN, 0.1% TFA. Following application of the
iodination reaction, the cartridge was washed with 2.5 mL
of 20% ACN and 0.1% TFA, and the iodinated hormone
METHODS
was eluted with three successive 0.5 mL aliquots of 50%
Rat PTH 1-34 and Nle 8,21Tyr34-rat PTH [1–34]NH2 ACN, 0.1% TFA. The peak tube was diluted in 1% BSA
were obtained from Bachem (Torrance, CA, USA). Ace- and aliquots were stored at 80C.
tonitrile was obtained from EM Science (Cherry Hill, NJ,
USA). 125I was purchased from Amersham Pharmacia Studies of PTH binding
Biotech (Piscataway, NJ, USA). 32P-CTP was purchased The medium was removed from confluent cultures of
from Amersham Life Science (Arlington Heights, IL, UMR106-01 cells, and the cells were washed twice with
USA). UMR 106-01 osteoblast-like cells were provided MEM containing 5% FBS at 10C. Following addition
by Dr. Nicola Partridge, Robert Woods Johnson Medical of PTH 106 mol/L to duplicate wells for determination
School (Piscataway, NJ, USA). All other reagents were of non-specific binding, all wells were incubated with
purchased from Sigma-Aldrich Company (St. Louis, 5  104 cpm of 125I Nle8,21Tyr34-rat PTH [1-34]NH2. For
MO, USA), unless otherwise indicated, and were of the studies of competitive inhibition binding, increasing con-
highest grade available. centrations of PTH were added to duplicate wells in
addition to radiolabeled PTH. Incubations were contin-
Cell culture
ued for three hours at 10C. The cells were then washed
Studies were performed in cultures of UMR 106-01 three times with cold MEM–5% FBS and phosphate-
osteoblast-like cells between passages 14 and 24. Cells buffered saline (PBS). The cells were solubilized in 0.1
were grown to confluence in minimum essential medium mol/L sodium hydroxide and the radioactivity quanti-
(MEM) supplemented with 5% fetal bovine serum tated. Specific binding was corrected for protein content
(FBS), penicillin and streptomycin. Confluent cultures per well.
were incubated in medium containing concentrated HCl
Studies of PTH/PTHrP-receptor mRNA(5, 10 and 15 L per 9 mL of growth medium resulting
in a pH of 7.3, 7.2 and 7.1, respectively). The culture Total RNA was isolated from cultured cells using the
medium was changed daily and there was no significant TRIzol method as described by manufacturer (Life
difference in pH during the incubation period. Control Technologies, Grand Island, NY, USA). PTH/PTHrP
cultures were incubated in regular medium, which has a receptor mRNA was measured by Northern blotting us-
pH of 7.4. ing a probe consisting of nucleotides 439 to 768 of the
rat PTH/PTHrP-receptor cDNA prepared by reverse
PTH-stimulated cAMP production transcription-polymerase chain reaction (RT-PCR) from
The medium was aspirated from confluent 12-well cul- rat kidney RNA, cloned into pCRII and sequenced to
ture plates of UMR 106-01 cells, and the cells were confirm identity with the published sequence of the
washed three times with Krebs-Henseleit solution. PTH cloned rat PTH/PTHrP receptor. Northern blot was per-
(108 mol/L) was added for five minutes in the presence formed using the Northern Max-Gly kit as described
of 1 mmol/L 3-isobutyl-1-methylxanthine in a total vol- by the manufacturer (Ambion, Austin, TX, USA).
ume of 0.5 mL. The reactions were terminated with the Briefly, 20 g of total RNA was mixed 1:1 with Glyoxal
addition of 0.1 mL of 1.8 mol/L perchloric acid. After Load Dye and the mixture was incubated for 30 minutes
five minutes, the cell extracts were neutralized with 0.1 in a 50C water bath. The samples were then applied to
mL of 3 mol/L KHCO3, the volume was brought to 1 mL 1% Agarose LE gel and electrophoresed at 100 volts for
with 20 mmol/L MES [2-(n-morpholino) ethanesulfonic one hour. After transferring to nylon membranes, the
acid, pH 6.2], and cAMP was measured by radioimmuno- RNA was bound by UV cross-linking (Stratalinker; Stra-
assay as previously described [11]. tegene Cloning Systems, La Jolla, CA, USA). The filters
were prehybridized for one hour at 42C in Ultrahyb
Iodination of PTH solution. The filters were probed with 32P-CTP radiola-
Five micrograms of Nle8,21Tyr34-rat PTH [1–34]NH2 beled cDNA for 16 to 20 hours, washed with 2 standard
were iodinated with 25 g of chloramine T in the pres- sodium citrate (SSC)/0.1% sodium dodecyl sulfate (SDS)
for seven minutes at 42C. The filters were analyzed byence of 2 mCi of 125I. The reaction was terminated with
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Fig. 1. Dose response of the effect of metabolic acidosis on parathyroid
hormone (PTH)-stimulated cAMP generation. Cells were exposed to
acidic medium with pH ranging from 7.3 to 7.1 for 48 hours. Control
cultures were exposed to medium with pH 7.4. cAMP generation follow-
ing acute stimulation with PTH (108 mol/L for 5 min) was determined
by radioimmunoassay. The values represent the mean  SEM from 4
to 6 different experiments. Symbols are: () basal; () PTH stimulated;
*P  0.05 compared to control.
phosphorimager (Molecular Dynamics, Sunnyvale, CA, Fig. 2. Time course of the effects of metabolic acidosis on PTH-stimu-
USA). After analysis, the filters were then stripped and lated cAMP generation. The cells were exposed to acidic medium with
pH 7.2 for the times indicated. cAMP generation following acute stimu-reprobed with radiolabeled cDNA for GAPDH. The
lation with PTH (108 mol/L for 5 min) was determined by radioimmu-PTH/PTHrP receptor bands were normalized relative to noassay. The values represent the mean SEM from 5 different experi-
the GAPDH band using Image Quant software. ments. *P  0.05 compared to time 0.
Statistical analysis
Data were analyzed using the Student t test. For analy-
bolic acidosis on PTH-stimulated cAMP generation.sis of multiple groups, analysis of variance (ANOVA)
Cells were exposed to medium with pH 7.2 for up to 72was used followed by the Student t test with Bonferroni
hours. The increase in cAMP generation in response tocorrection. Differences between groups were considered
PTH was evident after 12 hours of exposure to acidicsignificant when P 0.05. Data are expressed as mean
medium and reached a plateau between 48 and 72 hoursstandard error of the mean.
of exposure.
RESULTS Effect of metabolic acidosis on PTH binding
Effect of metabolic acidosis on basal and To determine if the stimulatory effect of metabolic
PTH-stimulated cAMP generation acidosis on PTH-stimulated cAMP generation was due
to an increase in PTH binding to its receptor, we exam-To assess the effect of metabolic acidosis on PTH-stimu-
ined the effect of metabolic acidosis on 125I PTH bindinglated cAMP generation, confluent cultures of UMR106-01
in confluent cultures of UMR 106-01 cells. As shown inosteoblast-like cells were exposed to acidic medium with
Figure 3, exposure to acidic medium with progressivelypH ranging from 7.3 to 7.1. for 48 hours. As shown in
decreasing pH resulted in a dose dependent increase inFigure 1, metabolic acidosis enhanced the ability of the
PTH binding. In control cultures (pH 7.4), PTH bindingcells to respond to acute stimulation with PTH with no
was 4616  308 cpm/mg protein. Incubation with acidicsignificant difference in the basal cAMP levels. The PTH-
medium increased PTH binding to 7801  859 cpm/mgstimulated cAMP generation in control cultures (pH 7.4)
protein at pH7.2 and 9279  1192 cpm/mg protein atwas 1978  294 pmol/culture/5 min. Cultures exposed to
pH 7.1 (P  0.05 for the different acidic media as com-acidic medium demonstrated increased PTH-stimulated
pared to control).cAMP generation with values reaching 3380  333 and
Competitive inhibition binding experiments revealed4968 929 pmol/culture/5 min at pH 7.2 and 7.1, respec-
that binding was increased at all concentrations of unla-tively (P  0.05 for the different acidic media as com-
beled PTH tested between 0.01 and 10 nmol/L (Fig. 4).pared to control). Although cAMP generation was higher
Scatchard analysis indicated that the increase in bindingat pH 7.1 as compared to pH 7.2, the difference did not
was due to an increase in receptor number with noreach statistical significance (P 	 0.058).
Figure 2 shows the time course for the effect of meta- change in affinity.
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bolic acidosis demonstrate an enhanced calcemic re-
sponse to PTH [13]. Studies by Bushinsky and Nilsson,
using neonatal mouse calvariae, have also demonstrated
enhanced PTH action in the setting of metabolic acidosis
in terms of calcium flux, osteoclastic -glucuronidase
activity and inhibition of osteoblastic collagen synthesis
[10]. PTH exerts its effect on target tissues by acting via
a G-protein coupled receptor, the PTH/PTHrP receptor,
which in bone is present in cells of the osteoblastic lin-
eage. The adenylate cyclase/cAMP system serves as one
of the major signal transduction pathways activated by
the PTH/PTHrP receptor. Based on previous findingsFig. 3. Dose response of the effect of metabolic acidosis on the specific
suggesting that metabolic acidosis may alter the actionsbinding of 125I Nle8,21Tyr34-rat PTH [1-34]NH2. Confluent cultures of
UMR-106-01 cells were exposed to acidic medium with pH 7.3 to 7.1 of PTH by affecting the PTH/PTHrP receptor/adenylate
for 48 hours. Control cultures were exposed to medium with pH 7.4. cyclase system [9, 14], we designed the present studiesBinding of 125I Nle8,21Tyr34-rat PTH [1-34]NH2 was quantitated and cor-
to examine the direct effect of metabolic acidosis onrected for protein. The values represent the mean  SEM from 6
different experiments. *P  0.05 compared to control. PTH/PTHrP receptors in UMR 106-01 osteoblast-like
cells. Our studies demonstrate that metabolic acidosis
increases PTH-stimulated cAMP generation, an effect
that was accompanied by increased binding of PTH to
Effect of metabolic acidosis on its receptor as well as increased levels of PTH/PTHrP
PTH/PTHrP-receptor mRNA receptor mRNA levels.
The effects of metabolic acidosis on the levels of PTH/ The effects of metabolic acidosis on PTH signaling
PTHrP-receptor mRNA were examined by Northern mechanisms have not been studied in detail. Our finding
analysis. As shown in Figure 5A, exposure to acidic me- of increased PTH-stimulated cAMP generation in re-
dium with decreasing pH resulted in a progressive in- sponse to metabolic acidosis is in agreement with previ-
crease in PTH/PTHrP-receptor mRNA. Densitometry ous studies using isolated perfused canine tibia [9]. In
of the levels of PTH/PTHrP-receptor mRNA normalized addition to increased PTH-stimulated cAMP generation,
by GAPDH showed an increase to 182 and 218% of we find that exposure of osteoblast-like cells to acidic
control at pH 7.2 and 7.1, respectively (Fig. 5B). The medium increases PTH binding, which is consistent with
difference in mRNA levels reached statistical signifi- previous studies in isolated perfused canine tibiae. In
cance at both pH 7.2 and pH 7.1 as compared to controls those experiments, lowering the pH of the perfusate
(P  0.05). Similarly, the difference in mRNA levels resulted in increased arteriovenous difference for iPTH
between pH 7.2 and 7.1 also was statistically significant across the perfused bone that could have been due to
(P  0.05). increased PTH binding [9]. Our present studies further
Figure 6 illustrates the time course for the effect of demonstrate that the increased PTH binding in response
acidic medium (pH 7.1) on PTH/PTHrP receptor mRNA to metabolic acidosis is associated with increased levels
levels. The increase in receptor mRNA levels was evi- of PTH/PTHrP receptor mRNA. Studies in canine kid-
dent after 12 hours and the difference from control val- ney have shown a decrease in PTH-stimulated cAMP
ues reached statistical significance after 24 and 48 hours generation in response to metabolic acidosis that was
(P  0.05 as compared to control in both cases). Simi- not associated with changes in PTH binding [14]. Thus,
larly, the difference in PTH/PTHrP receptor mRNA lev- it appears that there are variations in the effect of meta-
bolic acidosis on the PTH receptor/adenylate cyclaseels between the 24- and 48-hour time point also was
system in different tissues. Metabolic acidosis has beenstatistically significant.
shown to regulate the expression of a variety of genes
in bone cells [15–18]; however, the effect of metabolic
DISCUSSION acidosis on the PTH/PTHrP receptor gene has not been
It is well accepted that metabolic acidosis inhibits os- examined. Interestingly, Biskobing and Fan have shown
teoblast function while enhancing osteoclast function [7], that exposure of mature osteoclasts to acidic medium
ultimately leading to skeletal demineralization. PTH also results in increased levels of calcitonin receptor mRNA
is known to enhance osteoclastic activity, a process that levels [18]. Since the genes coding for the PTH/PTHrP
requires the presence of osteoblasts [12]. Several lines receptor and the calcitonin receptor are highly homolo-
of evidence have suggested that the effects of PTH in gous [19], it is possible that the regulation of both genes
bone may be accentuated by metabolic acidosis. Studies by metabolic acidosis may involve similar regulatory mo-
tifs. The RANK/RANKL/OPG system plays a centralby Beck and Webster have shown that rats with meta-
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Fig. 4. Competitive inhibition of equilibrium
binding of 125I Nle8,21Tyr34-rat PTH [1-34]NH2.
Confluent cultures of UMR 106-01 cells were
exposed to control (, pH 7.4) or acidic (,
pH 7.1) medium. Binding of 125I Nle8,21Tyr34-
rat PTH [1-34]NH2 was examined in the pres-
ence of increasing concentrations of unlabeled
PTH. The inset shows a Scatchard analysis of
the data.
Fig. 5. Dose response of the effect of metabolic acidosis on PTH/ Fig. 6. Time course of the effect of metabolic acidosis on PTH/PTHrP
PTHrP receptor mRNA (A). Confluent cultures of UMR-106-01 cells receptor mRNA (A ). Confluent cultures of UMR-106-01 cells were
were exposed to control medium (pH 7.4) or acidic medium with pH exposed to control medium (pH 7.4) or acidic medium with pH 7.1 for
7.3 to 7.1 for 48 hours. Total RNA was isolated and PTH/PTHrP the time periods indicated. Total RNA was isolated and PTH/PTHrP
receptor mRNA levels were examined using Northern analysis. The receptor mRNA levels were examined using Northern analysis. The
membranes were stripped and reprobed using a cDNA for GAPDH. membranes were stripped and reprobed using a cDNA for GAPDH.
Densitometric analysis of the levels of PTH/PTHrP receptor mRNA Densitometric analysis of the levels of PTH/PTHrP receptor mRNA
corrected for GAPDH mRNA (B ). The values represent the mean  corrected for GAPDH mRNA (B). The values represent the mean 
SEM from 4 different experiments. *P  0.05 compared to control. SEM from 5 different experiments. *P  0.05 compared to time 0.
role in the regulation of osteoblast-mediated osteoclastic chaiporn et al reported bone histomorphometric analysis
function, and PTH is known to affect this system in a on 14 patients with distal renal tubular acidosis. The
direction that would favor osteoclastic activity [20–23]. results showed a significant decrease in bone formation
However, the effects of acidosis on the individual ele- rate with increased osteoid surface and volume; however,
ments of the RAN/RANKL/OPG system have not been only one patient had evidence of osteomalacia [39]. The
elucidated at the present time. interpretation of bone histology in human acidotic dis-
The effects of metabolic acidosis on bone remodeling ease may be complicated by associated changes in cal-
are rather complex. In animal studies, the induction of cium and phosphate metabolism, which can have effects
metabolic acidosis leads to decreased bone mass and on bone independent of the effects of acidosis.
increased osteoclastic bone resorption without a miner- Metabolic acidosis and hyperparathyroidism often co-
alization defect [24–29]. Studies in humans have demon- exist in the setting of chronic kidney disease and both
strated an association between metabolic acidosis and contribute to the pathogenesis of renal bone disease. The
present studies would suggest that metabolic acidosis,osteomalacia [30–38]. A recent study by Domrongkit-
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parathyroid hormone in the isolated perfused canine kidney: Re-by up-regulating PTH/PTHrP receptors, may potentially
versal of altered receptor-adenylate cyclase system by guanosine
worsen the effects of PTH on bone. In this regard, Lefeb- triphosphate in vitro. Endocrinology 111:1311–1317, 1982
vre et al studied the effect of bicarbonate therapy on 12. Hock JM, Fitzpatrick AF, Bilezikian JP: Actions of parathyroid
hormone, in Principles of Bone Biology (vol 1), edited by Bilezi-bone in patients on hemodialysis. They found that cor-
kian JP, Raisz LG, Rodan AR, San Diego, Academic Press, 2002,rection of metabolic acidosis was associated with less pp 463–481
progression of hyperparathyroid bone disease. However, 13. Beck N, Webster SK: Effects of acute metabolic acidosis on para-
thyroid hormone action and calcium mobilization. Am J Physiolbicarbonate administration also was associated with
230:127–131, 1976lower levels of PTH [40]; thus, the precise contribution 14. Bellorin-Font E, Humpierres J, Weisinger JR, et al: Effect of
of metabolic acidosis to the pathogenesis of hyperpara- metabolic acidosis on the PTH receptor-adenylate cyclase system
of canine kidney. Am J Physiol 249:F566–F572, 1985thyroid bone disease remains to be determined.
15. Frick KK, Jiang L, Bushinsky DA: Acute metabolic acidosisIn summary, the present studies demonstrate that met- inhibits the induction of osteoblastic egr-1 and type 1 collagen.
abolic acidosis increases PTH-stimulated cAMP regula- Am J Physiol 272:C1450–C1456, 1997
16. Frick KK, Bushinsky DA: Chronic metabolic acidosis reversiblytion as well as PTH binding and PTH/PTHrP receptor
inhibits extracellular matrix gene expression in mouse osteoblasts.mRNA levels in UMR 106-01 cells. The up-regulation
Am J Physiol 275:F840–F847, 1998
of PTH/PTHrP receptors may alter the effects of PTH 17. Frick KK, Bushinsky DA: In vitro metabolic and respiratory
acidosis selectively inhibit osteoblastic matrix gene expression. Amin bone cells and may play a role in the alterations of
J Physiol 277:F750–F755, 1999bone cell function observed in metabolic acidosis. Future
18. Biskobing DM, Fan D: Acid pH increases carbonic anhydrase II
studies are needed to clarify the molecular mechanisms and calcitonin receptor mRNA expression in mature osteoclasts.
Calcif Tissue Int 67:178–183, 2000responsible for the abnormalities in bone remodeling
19. Juppner H, Abou-Samra AB, Freeman M, et al: A G protein-associated with metabolic acidosis.
linked receptor for parathyroid hormone and parathyroid hor-
mone-related peptide. Science 254:1024–1026, 1991
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